Anthony G. Rapsomanikis Managing Director

Anthony G. Rapsomanikis is a Managing Director at HCRx. Mr. Rapsomanikis opened HCRx’s San Francisco office in 2015, and is now focused primarily on HCRx’s activities in the mid-Atlantic region, including the greater NY metropolitan area, where he is responsible for transaction sourcing and structuring. Since joining HCR in 2012, Mr. Rapsomanikis has worked on investments representing over $1.6 billion in transaction value. Prior to joining HCRx, Mr. Rapsomanikis worked as an analyst in the healthcare investment banking group at Stifel Nicolaus Weisel and its predecessor firm Thomas Weisel Partners, where he was focused on mergers and acquisitions, and debt and equity financings. Prior to Stifel, Mr. Rapsomanikis was an analyst at Silverwood Partners. Mr. Rapsomanikis currently serves as a member of the Board of Directors of Valinor Pharmaceuticals. Mr. Rapsomanikis holds a B.B.A., cum laude, from the University of Massachusetts, Amherst.